Latest IR information
IR News
- 2025.12.01
- Notice Regarding the Monthly Exercise Status of the 58th and 65th Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued through Third-Party Allotment
- 2025.12.01
- Notice of Appointment of Corporate Officers
- 2025.11.27
- SymBio Presents Research Findings on Brincidofovir for the Treatment of Malignant Brain Tumors (Glioblastoma) at the Society for Neuro-Oncology (SNO) Annual Meeting
- 2025.11.20
- Prioritizing and Focusing Resources on the Global Phase 3 Trial of IV Brincidofovir for Adenovirus Infection Post-HSCT - Portfolio Reprioritization
- 2025.11.17
- SymBio Obtains Clinical Trial Authorization in the United Kingdom for the Global Phase 3 Clinical Study of Intravenous Brincidofovir in Adenovirus Infection Following Hematopoietic Stem Cell Transplantation